Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Current Assets (2022 - 2025)

Core Laboratories (CLB) has 4 years of Current Assets data on record, last reported at $226.9 million in Q3 2025.

  • For Q3 2025, Current Assets fell 3.53% year-over-year to $226.9 million; the TTM value through Sep 2025 reached $226.9 million, down 3.53%, while the annual FY2024 figure was $226.6 million, 1.56% up from the prior year.
  • Current Assets reached $226.9 million in Q3 2025 per CLB's latest filing, down from $237.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $237.7 million in Q2 2025 and bottomed at $211.7 million in Q4 2022.
  • Average Current Assets over 4 years is $228.8 million, with a median of $228.8 million recorded in 2025.
  • Peak YoY movement for Current Assets: rose 5.4% in 2023, then decreased 3.53% in 2025.
  • A 4-year view of Current Assets shows it stood at $211.7 million in 2022, then increased by 5.4% to $223.1 million in 2023, then increased by 1.56% to $226.6 million in 2024, then increased by 0.14% to $226.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $226.9 million in Q3 2025, $237.7 million in Q2 2025, and $228.8 million in Q1 2025.